|
|
|
|
|
Bárbara Costa, Rita Matos, Irina Amorim, Fátima Gärtner and Nuno Vale
The breast cancer therapies available are insufficient, especially since first-line treatments, such as paclitaxel, result in drug resistance and their toxicity often limits their concentration. Strategies like drug repurposing are beneficial, and novel ...
ver más
|
|
|
|
|